title: Resistance to the actions of atrial natriuretic factor in insulin-dependent diabetic hypertensives and improvement with angiotensin converting enzyme inhibitor treatment.
authors.affiliation: Istituto di Medicina Interna, University of Padua, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Fioretto
authors.forename: B
authors.initials: B
authors.lastname: Muollo
authors.forename: G P
authors.initials: GP
authors.lastname: Ben
authors.forename: F
authors.initials: F
authors.lastname: Mollo
authors.forename: F
authors.initials: F
authors.lastname: Frigato
authors.forename: G
authors.initials: G
authors.lastname: Opocher
authors.forename: R
authors.initials: R
authors.lastname: Trevisan
authors.forename: A
authors.initials: A
authors.lastname: Carraro
authors.forename: M
authors.initials: M
authors.lastname: Sambataro
authors.forename: R
authors.initials: R
authors.lastname: Nosadini
mesh_terms: D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D009320:Atrial Natriuretic Factor / Q000097:blood / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D017315:Cilazapril; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006400:Hematocrit; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D011724:Pyridazines / Q000627:therapeutic use*; D012079:Renal Circulation / Q000187:drug effects; D012964:Sodium / Q000378:metabolism
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D011724:Pyridazines; D017315:Cilazapril; D009320:Atrial Natriuretic Factor; D012964:Sodium